Page last updated: 2024-08-16

1,6-bis(cyclohexyloximinocarbonyl)hexane and am 251

1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with am 251 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, T; Yokotani, K1
Rubio, ME; Tzounopoulos, T; Zhao, Y1
Cui, Y; Georges, F; Grandes, P; Lafourcade, M; Lassalle, O; Manzoni, OJ; Puente, N; Venance, L1
Fichna, J; Misicka, A; Sacharczuk, M; Wasilewski, A1

Other Studies

4 other study(ies) available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and am 251

ArticleYear
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
    European journal of pharmacology, 2008, Mar-17, Volume: 582, Issue:1-3

    Topics: Adrenal Medulla; Animals; Arachidonic Acids; Arginine Vasopressin; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catecholamines; Cyclohexanones; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Epinephrine; Glycerides; Indoles; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Norepinephrine; Organophosphonates; Piperidines; Pyrazoles; Rats; Rats, Wistar

2008
Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem.
    Journal of neurophysiology, 2009, Volume: 101, Issue:5

    Topics: Animals; Animals, Newborn; Auditory Pathways; Benzoxazines; Biophysics; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cochlear Nucleus; Cyclohexanones; Dose-Response Relationship, Drug; Electric Stimulation; Endocannabinoids; In Vitro Techniques; Lipoprotein Lipase; Membrane Potentials; Mice; Mice, Inbred ICR; Microscopy, Immunoelectron; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Patch-Clamp Techniques; Piperidines; Protease Inhibitors; Pyrazoles; Receptor, Cannabinoid, CB1; Synaptic Potentials; Time Factors

2009
Polymodal activation of the endocannabinoid system in the extended amygdala.
    Nature neuroscience, 2011, Nov-06, Volume: 14, Issue:12

    Topics: Animals; Arachidonic Acids; Biophysics; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cannabinoid Receptor Modulators; Chromones; Cyclohexanones; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glycerides; In Vitro Techniques; Long-Term Synaptic Depression; Neurons; Nimodipine; Patch-Clamp Techniques; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Septal Nuclei; Signal Transduction; Synapses; Time Factors; TRPV Cation Channels

2011
Modulation of the endocannabinoid system by the fatty acid amide hydrolase, monoacylglycerol and diacylglycerol lipase inhibitors as an attractive target for secretory diarrhoea therapy.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2017, Volume: 68, Issue:4

    Topics: Amidohydrolases; Animals; Benzodioxoles; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanones; Diarrhea; Endocannabinoids; Enzyme Inhibitors; Indoles; Lipoprotein Lipase; Male; Mice; Monoglycerides; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2017